Logo

Fluidigm Inks Nordic Distribution Pact with AME Bioscience

May 07, 2008
NEW YORK (GenomeWeb News) – Fluidigm said today it has signed up AME Bioscience to distribute its integrated fluidic circuits in the Nordic region.
 
Under the exclusive agreement, AME Bioscience will distribute Fluidigm’s BioMark systems to research customers in Norway, Sweden, Iceland, Finland, and Denmark.
 
The BioMark system, which has not been cleared or approved by the US Food and Drug Administration for use as a diagnostic, is used in real-time PCR, genotyping, cancer detection, and absolute quantification for research purposes.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.